Cargando…

Quantitative SPECT/CT Parameters in the Assessment of Transthyretin Cardiac Amyloidosis—A New Dimension of Molecular Imaging

Aims: Cardiac transthyretin amyloidosis (ATTR) represents the accumulation of misfolded transthyretin in the heart interstitium. Planar scintigraphy with bone-seeking tracers has long been established as one of the three main steps in the non-invasive diagnosis of ATTR, but lately, single-photon emi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gherghe, Mirela, Lazar, Alexandra Maria, Sterea, Maria-Carla, Spiridon, Paula Monica, Motas, Natalia, Gales, Laurentia Nicoleta, Coriu, Daniel, Badelita, Sorina Nicoleta, Mutuleanu, Mario-Demian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299638/ https://www.ncbi.nlm.nih.gov/pubmed/37367407 http://dx.doi.org/10.3390/jcdd10060242

Ejemplares similares

The New Radiolabeled Peptide (99m)TcEDDA/HYNIC-TOC: Is It a Feasible Choice for Diagnosing Gastroenteropancreatic NETs?
por: Gherghe, Mirela, et al.
Publicado: (2022)

Standardized Uptake Values on SPECT/CT: A Promising Alternative Tool for Treatment Evaluation and Prognosis of Metastatic Neuroendocrine Tumours
por: Gherghe, Mirela, et al.
Publicado: (2023)

Radiomics Analysis of [(18)F]FDG PET/CT Thyroid Incidentalomas: How Can It Improve Patients’ Clinical Management? A Systematic Review from the Literature
por: Gherghe, Mirela, et al.
Publicado: (2022)

Muscle involvement with pseudohypertrophy in systemic light chain amyloidosis: Case report
por: Draghici, Mirela, et al.
Publicado: (2021)

Understanding COVID Vaccination and Its Implication in Cancer Patients’ Imaging of Lymph Nodes by PET-CT
por: Gales, Laurentia Nicoleta, et al.
Publicado: (2022)

Quantitative Analysis of SPECT-CT Data in Metastatic Breast Cancer Patients—The Clinical Significance
por: Gherghe, Mirela, et al.
Publicado: (2022)

Quantitative vs. Qualitative SPECT-CT Diagnostic Accuracy in Bone Lesion Evaluation—A Review of the Literature
por: Mutuleanu, Mario-Demian, et al.
Publicado: (2023)

Clinical characteristics in patients with hereditary amyloidosis with Glu54Gln transthyretin identified in the Romanian population
por: Jercan, Andreea, et al.
Publicado: (2020)

Analysis of Efficacy-To-Safety Ratio of Angiogenesis-Inhibitors Based Therapies in Ovarian Cancer: A Systematic Review and Meta-Analysis
por: Simion, Laurentiu, et al.
Publicado: (2023)

Feasibility of Sentinel Lymph Node Biopsy in Breast Cancer Patients with Axillary Conversion after Neoadjuvant Chemotherapy—A Single-Tertiary Centre Experience and Review of the Literature
por: Lazar, Alexandra Maria, et al.
Publicado: (2023)

Quantitative Assessment of Treatment Response in Metastatic Breast Cancer Patients by SPECT-CT Bone Imaging—Getting Closer to PET-CT
por: Gherghe, Mirela, et al.
Publicado: (2023)

Long-Term Outcome of Patients with Stage II and III Muscle-Invasive Urothelial Bladder Cancer after Multimodality Approach. Which Is the Best Option?
por: Trifanescu, Oana Gabriela, et al.
Publicado: (2022)

Therapies beyond Physiological Barriers and Drug Resistance: A Pilot Study and Review of the Literature Investigating If Intrathecal Trastuzumab and New Treatment Options Can Improve Oncologic Outcomes in Leptomeningeal Metastases from HER2-Positive Breast Cancer
por: Trifănescu, Oana Gabriela, et al.
Publicado: (2023)

Progress and challenges in the treatment of cardiac amyloidosis: a review of the literature
por: Adam, Robert Daniel, et al.
Publicado: (2021)

Molecular Tweezers Targeting Transthyretin Amyloidosis
por: Ferreira, Nelson, et al.
Publicado: (2014)

Evaluating Cardiotoxicity in Breast Cancer Patients Treated with HER2 Inhibitors: Could a Combination of Radionuclide Ventriculography and Cardiac Biomarkers Predict the Cardiac Impact?
por: Gherghe, Mirela, et al.
Publicado: (2022)

Validation of a New Prognostic Score in Patients with Ovarian Adenocarcinoma
por: Trifanescu, Oana Gabriela, et al.
Publicado: (2023)

Tegsedi (Inotersen): An Antisense Oligonucleotide Approved for the Treatment of Adult Patients with Hereditary Transthyretin Amyloidosis
por: Gales, Luís
Publicado: (2019)

Real-World Clinical Outcomes and Adverse Events in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib: A Single-Center Retrospective Study
por: Moldovianu, Ana-Maria, et al.
Publicado: (2023)

Cardiac transthyretin amyloidosis (99m)Tc-DPD SPECT correlates with strain echocardiography and biomarkers
por: Löfbacka, Viktor, et al.
Publicado: (2020)

Hereditary transthyretin amyloidosis overview
por: Manganelli, Fiore, et al.
Publicado: (2020)

Transthyretin cardiac amyloidosis
por: Tomoaia, Raluca, et al.
Publicado: (2021)

Transthyretin cardiac amyloidosis
por: Porcari, Aldostefano, et al.
Publicado: (2022)

Modulation of the Mechanisms Driving Transthyretin Amyloidosis
por: Bezerra, Filipa, et al.
Publicado: (2020)

Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage
por: Law, Steven, et al.
Publicado: (2020)

Uncovering the Neuroprotective Mechanisms of Curcumin on Transthyretin Amyloidosis
por: Ferreira, Nelson, et al.
Publicado: (2019)

Hereditary transthyretine amyloidosis in Slovenia
por: Zidar, Janez
Publicado: (2015)

Multidisciplinary Approaches for Transthyretin Amyloidosis
por: Koike, Haruki, et al.
Publicado: (2021)

EGCG-Mediated Protection of Transthyretin Amyloidosis by Stabilizing Transthyretin Tetramers and Disrupting Transthyretin Aggregates
por: Zou, Huizhen, et al.
Publicado: (2023)

Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS)
por: Damy, Thibaud, et al.
Publicado: (2019)

Sex Differences in Wild-Type Transthyretin Amyloidosis: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)
por: Campbell, Courtney M., et al.
Publicado: (2022)

Specific Therapy for Transthyretin Cardiac Amyloidosis: A Systematic Literature Review and Evidence‐Based Recommendations
por: Marques, Nuno, et al.
Publicado: (2020)

Extracellular Vesicles Contribute to the Metabolism of Transthyretin Amyloid in Hereditary Transthyretin Amyloidosis
por: Yamaguchi, Hiroki, et al.
Publicado: (2022)

Frequency of hereditary transthyretin amyloidosis among elderly patients with transthyretin cardiomyopathy
por: Maestro‐Benedicto, Alba, et al.
Publicado: (2022)

Recent advances in transthyretin amyloidosis therapy
por: Ueda, Mitsuharu, et al.
Publicado: (2014)

Evolving landscape in the management of transthyretin amyloidosis
por: Hawkins, Philip N., et al.
Publicado: (2015)

Screening for hereditary transthyretin amyloidosis in Bulgaria
por: Nakov, Radislav, et al.
Publicado: (2021)

A Late Diagnosis of Transthyretin Amyloidosis
por: Pfirman, Kristopher S, et al.
Publicado: (2022)

Transthyretin Cardiac Amyloidosis: Underrecognized in the Underrepresented
por: Leedy, Douglas J., et al.
Publicado: (2023)

APPLY: A prospective observational study of clinical practice patterns of darbepoetin alfa use in patients with chemotherapy-induced anemia in Romania
por: Berbec, Nicoleta Mariana, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8c105cr8u7iaqicggece2kpri6